Riggs Asset Managment Co. Inc. Alnylam Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $360 Million
- Q2 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 17 shares of ALNY stock, worth $8,135. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17Holding current value
$8,135% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ALNY
# of Institutions
791Shares Held
115MCall Options Held
584KPut Options Held
648K-
Capital World Investors Los Angeles, CA16.8MShares$8.04 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.3MShares$6.36 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.57 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.44 Billion0.49% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.28MShares$2.05 Billion0.88% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $58.9B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...